Literature DB >> 22627451

Preoperative embolization for the treatment of cervical Castleman disease.

Alberto Sanchez-Ros-Sanchez1, Pedro Infante-Cossio, Alejandro Gonzalez-Garcia, Juan-Jose Borrero-Martin.   

Abstract

Castleman disease (CD) is a rare benign lymphoproliferative disorder commonly described as a hypervascular mass that causes progressive lymph node enlargement. Head and neck involvement occurs only in 15% to 20% of cases. The recommended treatment in solitary CD is radical resection. Few reports have described the use of angiographic study and preoperative embolization to minimize the intraoperative risk of hemorrhage. We report a clinical case of a solitary large painless, slow-growing mass located in the neck of a 34-year-old woman. Contrast-enhanced computed tomographic and magnetic resonance imaging scan demonstrated a well-defined mass with internal calcifications and peripheral vessels located in the posterior cervical space, extending inferiorly to the supraclavicular space, which moderately enhanced after contrast administration. In the preoperative arteriography, a hypervascularized mass was identified, which mainly received an arterial supply from thyrocervical trunk. Successful embolization with polyvinyl alcohol microparticles was performed, resulting in a significant reduction of intraoperative bleeding, allowing a subsequently safe removal of the tumor. Histopathologic examination corresponded to hyaline vascular-type CD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22627451     DOI: 10.1097/SCS.0b013e318251880f

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  5 in total

Review 1.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

2.  Clinical and molecular characteristics of unicentric mediastinal Castleman disease.

Authors:  Antoine Legras; Anne Tallet; Audrey Didelot; Aurélie Cazes; Claire Danel; Angela Hin; Raphaël Borie; Bruno Crestani; Yves Castier; Patrick Bagan; Françoise Le Pimpec-Barthes; Marc Riquet; Hélène Blons; Pierre Mordant
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08

4.  Castleman disease: Report of a case and review of literature on role of preoperative embolization.

Authors:  Meshal B Albesher; Saeed Alqahtani; Fareed R Alghamdi
Journal:  Int J Surg Case Rep       Date:  2022-05-18

5.  Retroperitoneal Castleman's disease: advocating a multidisciplinary approach for a rare clinical entity.

Authors:  Austin D Williams; Adriana Sanchez; Jun Steve Hou; Rene Rothstein Rubin; Mark E Hysell; Blake D Babcock; Mohammad F Shaikh; Michael S Weingarten; Wilbur B Bowne
Journal:  World J Surg Oncol       Date:  2014-02-04       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.